Clinical Trial Update: Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (pNFs)

View source ↗

Summary

This clinical trial update describes the development and validation of patient-reported outcome measures for Neurofibromatosis type 1 and plexiform neurofibroma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurofibromatosis Type
• Plexiform Neurofibromas

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Neurofibromatosis 1, Plexiform Neurofibromas | Status: RECRUITING